SEC Filing Summary: Hexindai Inc. (Form 6-K)
Business Context and Reporting Period
This Form 6-K was filed by Hexindai Inc., a foreign private issuer, for the month of December 2018. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing was signed by Zhang Qisen (Johnson), Chief Financial Officer, on December 28, 2018. The document serves as a report pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document consists primarily of cover page information and an exhibit index.
Material Changes
The filing text does not provide a clear value regarding material changes versus the prior comparable period. No comparative financial data or operational updates are included in the provided text.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The content is limited to administrative details and the inclusion of a press release as Exhibit 99.1, the text of which is not provided.
Key Facts for Investor Verification
- The registrant is Hexindai Inc., not Akso Health Group as indicated in the request metadata.
- The filing contains a press release (Exhibit 99.1) which likely holds the substantive information, but the text of the release is not included in the source data.
- No financial figures or operational metrics are present in the provided text.
- Investors should verify the full text of the referenced press release to obtain material information.